NS Pharma, Inc., headquartered in Paramus, New Jersey, has announced that its parent organization, Nippon Shinyaku Co., Ltd. of Kyoto, Japan, has signed a Sponsored Research Agreement (SRA) with Boston …
Swedish Orphan Biovitrum AB has published its 2025 Annual and Sustainability Report, highlighting the company’s achievements in advancing innovative therapies for people living with rare diseases. Sobi continues to prioritize …
Belief BioMed (“BBM”) and Grand Life Sciences Group Co., Ltd. (“Grand Life Sciences”) have entered into an exclusive partnership agreement. As part of the deal, Belief BioMed will provide Grand …
Noncommunicable diseases (NCDs) are the world’s leading cause of death, creating an immense strain on individuals, healthcare systems, and economies. Every year, around 18 million people die prematurely—before reaching 70—from …
GileadNews: In partnership with Kite Pharma, we are excited to share groundbreaking cancer research at this year’s American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) conferences. Our …
